Methods of therapy and diagnosis using targeting of cells that express LAX

Details for Australian Patent Application No. 2003302733 (hide)

Owner NUVELO, INC.

Inventors Emtage, Peter C. R.

Agent FB Rice

Pub. Number AU-A-2003302733

PCT Number PCT/US2003/0379

PCT Pub. Number WO2004/053061

Priority 10/304,234 26.11.02 US

Filing date 25 November 2003

Wipo publication date 30 June 2004

Event Publications

29 July 2004 Complete Application Filed

  Priority application(s): 10/304,234 26.11.02 US

5 August 2004 Application Open to Public Inspection

  Published as AU-A-2003302733

5 July 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003302734-Proteorhodopsin mutants with improved optical characteristics

2003302732-METHOD FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF